China Biologic Produ (CBPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBPO | XENE | CRSP | ||
| Company | China Biologic Produ | Xenon Pharmaceuticals Inc | Crispr Therapeutics Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 118.01 | 58.54 | 47.89 | ||
| High | 120.05 | 59.44 | 49.95 | ||
| Low | 117.27 | 56.57 | 47.89 | ||
| Latest | 119.99 | 56.69 | 48.80 | ||
| Change | +1.98 | -1.46 | +1.23 | ||
| % Change | +1.68% | -2.51% | +2.59% | ||
| Volume | 390,900 | 959,279 | 1,064,351 | ||
| 20-Day Average Volume | 113,045 | 2,350,298 | 2,337,643 | ||
| Previous Close | 118.01 | 58.15 | 47.57 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 118.25 | 54.92 | 49.35 | ||
| 20-Day Raw Stochastic | 97.99% | 68.56% | 30.70% | ||
| 20-Day Relative Strength | 65.93 | 61.47 | 46.87 | ||
| Weighted Alpha | +12.44 | +79.13 | +25.52 | ||
| Today's Opinion | 56% Buy | 100% Buy | 100% Sell | ||
| Previous Opinion | 8% Sell | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.45% since 04/13/21 | +2.12% since 03/25/26 | +3.93% since 03/25/26 | ||
| Low | 117.27 on 04/20/21 | 53.62 on 03/30/26 | 44.12 on 03/30/26 | ||
| High | 120.05 on 04/20/21 | 59.13 on 04/01/26 | 49.95 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | +1.82% since 03/19/21 | +31.27% since 02/27/26 | -18.62% since 02/27/26 | ||
| Low | 117.06 on 03/23/21 | 41.05 on 03/06/26 | 44.12 on 03/30/26 | ||
| High | 120.05 on 04/20/21 | 63.95 on 03/10/26 | 61.00 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | +1.27% since 01/20/21 | +26.62% since 12/31/25 | -6.67% since 12/31/25 | ||
| Low | 115.69 on 01/27/21 | 39.29 on 01/20/26 | 44.12 on 03/30/26 | ||
| High | 120.05 on 04/20/21 | 63.95 on 03/10/26 | 61.76 on 02/26/26 | ||
| 6-Month | |||||
| %Chg | +5.61% since 10/20/20 | +45.07% since 10/01/25 | -26.03% since 10/01/25 | ||
| Low | 112.29 on 10/26/20 | 37.23 on 11/07/25 | 44.12 on 03/30/26 | ||
| High | 120.05 on 04/20/21 | 63.95 on 03/10/26 | 78.48 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,722,806 | 4,837,499 | 4,566,007 | ||
| Shares Outstanding, K | 39,360 | 83,190 | 95,985 | ||
| Annual Sales | 524,370,000 | 7,500,000 | 3,510,000 | ||
| Annual Net Income | 152,290,000 | -345,910,000 | -581,600,000 | ||
| Last Quarter Sales | 112,100,000 | 0 | 860,000 | ||
| Last Quarter Net Income | 23,680,000 | -105,260,000 | -130,610,000 | ||
| 60-Month Beta | 0.42 | 0.91 | 1.72 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.31 on 02/26/26 | -1.37 on 02/12/26 | ||
| Latest Earnings Date | 05/19/21 | 05/11/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 29.28 | 0.00 | 0.00 | ||